New hope for advanced stomach cancer patients in major drug trial

NCT ID NCT05702229

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing several new combinations of cancer drugs for people with advanced stomach or gastroesophageal cancer that cannot be removed by surgery. The goal is to see if these combinations can shrink tumors, delay cancer growth, and are safe for patients. The trial is for adults who have not yet received treatment for their advanced cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Los Angeles, California, 90017, United States
Research Site
WITHDRAWN

Los Angeles, California, 90095, United States
Research Site
RECRUITING

Baton Rouge, Louisiana, 70817, United States
Research Site
RECRUITING

Grand Rapids, Michigan, 49503, United States
Research Site
WITHDRAWN

New Hyde Park, New York, 11042, United States
Research Site
WITHDRAWN

New York, New York, 10028, United States
Research Site
RECRUITING

New York, New York, 10065, United States
Research Site
WITHDRAWN

New York, New York, 11210, United States
Research Site
WITHDRAWN

Shirley, New York, 11967, United States
Research Site
WITHDRAWN

The Bronx, New York, 10469, United States
Research Site
WITHDRAWN

Pittsburgh, Pennsylvania, 15212, United States
Research Site
RECRUITING

Beijing, 100142, China
Research Site
RECRUITING

Hangzhou, 310003, China
Research Site
RECRUITING

Hangzhou, 310020, China
Research Site
RECRUITING

Harbin, 150081, China
Research Site
RECRUITING

Hefei, 230031, China
Research Site
COMPLETED

Kunming, 650118, China
Research Site
RECRUITING

Wuhan, 430079, China
Research Site
RECRUITING

Yinchuan, 750004, China
Research Site
RECRUITING

Zhengzhou, 450052, China
Research Site
RECRUITING

Chūōku, 104-0045, Japan
Research Site
RECRUITING

Kashiwa, 227-8577, Japan
Research Site
RECRUITING

Sunto-gun, 411-8777, Japan
Research Site
RECRUITING

Seoul, 03080, South Korea
Research Site
RECRUITING

Seoul, 03722, South Korea
Research Site
RECRUITING

Seoul, 05505, South Korea
Research Site
RECRUITING

Seoul, 06351, South Korea
Research Site
RECRUITING

Barcelona, 08035, Spain
Research Site
RECRUITING

Elche(Alicante), 03202, Spain
Research Site
RECRUITING

L'Hospitalet de Llobregat, 08908, Spain
Research Site
RECRUITING

Madrid, 28007, Spain
Research Site
RECRUITING

Madrid, 28040, Spain
Research Site
RECRUITING

Santander, 39008, Spain
Research Site
RECRUITING

Hsinchu, 300, Taiwan
Research Site
RECRUITING

Kaohsiung City, 80756, Taiwan
Research Site
RECRUITING

Taichung, 404, Taiwan
Research Site
RECRUITING

Tainan, 70403, Taiwan
Research Site
RECRUITING

Taipei, 10002, Taiwan
Research Site
RECRUITING

Taipei, 11259, Taiwan
Research Site
RECRUITING

Taoyuan District, 333, Taiwan
Research Site
WITHDRAWN

Edinburgh, EH4 2XU, United Kingdom
Research Site
RECRUITING

Leeds, LS9 7TF, United Kingdom
Research Site
RECRUITING

London, EC1M 6BQ, United Kingdom
Research Site
RECRUITING

Oxford, OX3 7LE, United Kingdom

Conditions

Explore the condition pages connected to this study.

GASTRIC CANCER